Trials / Unknown
UnknownNCT01548326
Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Nematollah Jonaidi Jafari · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether short-term Atorvastatin can increase the immunity response to hepatitis B vaccination in vaccine Nonresponders.
Detailed description
20 person of vaccinated individuals who have HBsAb\<10 after 3 dose hepatitis B vaccination who called Nonresponders will be randomly allocated in 2 groups. one group receive short-term Atorvastatin and other group receive placebo.both group will be vaccinated with hepatitis B vaccine and then immunity response will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | one 40 mg Atorvastatin tablet orally per day for 10 days |
| DRUG | placebo | one Placebo tablet orally per day for 10 days |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2012-03-08
- Last updated
- 2012-03-08
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01548326. Inclusion in this directory is not an endorsement.